Akihiro Homma

5.4k total citations
270 papers, 3.1k citations indexed

About

Akihiro Homma is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Akihiro Homma has authored 270 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Otorhinolaryngology, 133 papers in Surgery and 75 papers in Oncology. Recurrent topics in Akihiro Homma's work include Head and Neck Cancer Studies (121 papers), Head and Neck Surgical Oncology (80 papers) and Ear and Head Tumors (44 papers). Akihiro Homma is often cited by papers focused on Head and Neck Cancer Studies (121 papers), Head and Neck Surgical Oncology (80 papers) and Ear and Head Tumors (44 papers). Akihiro Homma collaborates with scholars based in Japan, United States and Australia. Akihiro Homma's co-authors include Satoshi Fukuda, Tomohiro Sakashita, Hiroki Shirato, Satoshi Kano, Hiromitsu Hatakeyama, Nobuhiko Oridate, Takatsugu Mizumachi, Yuji Nakamaru, Noriyuki Fujima and Kohsuke Kudo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Akihiro Homma

234 papers receiving 3.0k citations

Peers

Countries citing papers authored by Akihiro Homma

Since Specialization

Citations

This map shows the geographic impact of Akihiro Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Homma more than expected).

Fields of papers citing papers by Akihiro Homma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Homma. The network helps show where Akihiro Homma may publish in the future.

Co-authorship network of co-authors of Akihiro Homma

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Homma. A scholar is included among the top collaborators of Akihiro Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Homma. Akihiro Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group 2025 ·Frontiers in Oncology ·Kôichi Yasuda, (unknown), Kazuto Matsuura, (unknown), Yoshitaka Honma, Yoshinori Imamura, Kaoru Tanaka, Sadamoto Zenda, Takuma Onoe, Takeshi Kodaira, (unknown), Hidefumi Aoyama, Nobuhiro Hanai, Akihiro Homma	0
2	A Case of Cochlear Implantation in a Deaf Patient With Eosinophilic Otitis Media in Whom Post-implantation Hearing Threshold Improved After Introduction of Dupilumab 2024 ·Cureus ·Atsushi Fukuda, (unknown), Shinya Morita, Keishi Fujiwara, Akihiro Homma	0
3	Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations 2023 ·Auris Nasus Larynx ·(unknown), Satoshi Kano, Kanako C. Hatanaka, Takayoshi Suzuki, (unknown), (unknown), Yuji Nakamaru, Masanobu Suzuki, Yutaka Hatanaka, Akihiro Homma	0
4	Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan 2023 ·International Journal of Clinical Oncology ·Kôichi Yasuda, (unknown), Satoshi Kano, Jun Taguchi, Daisuke Kawakita, (unknown), Kentaro Nishioka, Takashi Mori, (unknown), (unknown), Yasushi Shimizu, (unknown), Seiichi Yoshimoto, Ken‐ichi Nibu, Akihiro Homma, Hidefumi Aoyama	2
5	Three Cases of Squamous Cell Carcinoma of the Lacrimal Drainage System 2023 ·Practica Oto-Rhino-Laryngologica ·(unknown), (unknown), Takayoshi Suzuki, Satoshi Kano, Akihiro Homma	0
6	Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study 2023 ·EJNMMI Research ·(unknown), Kenji Hirata, Keiichi Magota, Shirô Watanabe, (unknown), (unknown), Jun Taguchi, (unknown), (unknown), (unknown), (unknown), Yasushi Shimizu, Ichiro Kinoshita, (unknown), Yasushi Tsuji, Akihiro Homma, Hirotoshi Dosaka‐Akita	1
7	Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE) 2023 ·BMC Cancer ·Tomoya Yokota, Sadamoto Zenda, Takeshi Kodaira, Naomi Kiyota, Yasushi Fujimoto, Koichiro Wasano, Ryo Takahashi, Takashi Mizowaki, Akihiro Homma, Keita Sasaki, Ryunosuke Machida, Yuta Sekino, Haruhiko Fukuda	0
8	Progress and emerging strategies to preserve function in the treatment of sinonasal cancer 2023 ·Head & Neck ·K. Thomas Robbins, Ohad Ronen, Nabil F. Saba, Primož Strojan, Vincent Vander Poorten, Antti Mäkitie, Fernando López, Juan P. Rodrigo, Akihiro Homma, Ehab Y. Hanna, Alfio Ferlito	2
9	Current topics and management of head and neck sarcomas 2023 ·Japanese Journal of Clinical Oncology ·Kenya Kobayashi, Nobuhiro Hanai, Seiichi Yoshimoto, Yuki Saito, Akihiro Homma	3
10	Utility of the deep learning technique for the diagnosis of orbital invasion on CT in patients with a nasal or sinonasal tumor 2022 ·Cancer Imaging ·Junichi Nakagawa, Noriyuki Fujima, Kenji Hirata, Minghui Tang, (unknown), Jun Suzuki, Taisuke Harada, Yohei Ikebe, Akihiro Homma, Satoshi Kano, Kazuyuki Minowa, Kohsuke Kudo	14
11	Systemic therapy for salivary gland malignancy: current status and future perspectives 2022 ·Japanese Journal of Clinical Oncology ·Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, (unknown), Ichiro Ota, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Kôichi Yasuda, Shunji Takahashi, Tomoya Yokota, Susumu Okano, Kaoru Tanaka, (unknown), (unknown), Akihiro Homma	22
12	Management of elderly patients with head and neck cancer 2022 ·Japanese Journal of Clinical Oncology ·Ryo Ishii, Akira Ohkoshi, Naomi Kiyota, (unknown), Kôichi Yasuda, Yoshinori Imamura, Yuki Saito, Akihiro Homma	7
13	Pretreatment elevated mean corpuscular volume as an indicator for high risk esophageal second primary cancer in patients with head and neck cancer 2022 ·Auris Nasus Larynx ·(unknown), Satoshi Kano, (unknown), (unknown), Akihiro Homma	0
14	Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial 2021 ·Journal of Clinical Oncology ·Yasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto, Kouki Miura, Junkichi Yokoyama, Shigeru Hirano, Hirokazu Uemura, Masashi Sugasawa, Tomokazu Yoshizaki, Akihiro Homma, Kazuaki Chikamatsu, Mikio Suzuki, Akihiro Shiotani, Takashi Matsuzuka, Naoyuki Kohno, Masakazu Miyazaki, Isao Oze, Keitaro Matsuo, Shigeru Kosuda, Yasushi Yatabe	71
15	Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System 2019 ·The Journal of International Advanced Otology ·Atsushi Fukuda, Shinya Morita, Yuji Nakamaru, (unknown), Keishi Fujiwara, Akihiro Homma	17
16	A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition) 2019 ·Japanese Journal of Clinical Oncology ·(unknown), Nobuya Monden, Takahiro Asakage, Naomi Kiyota, Akihiro Homma, (unknown), Nobuhiro Hanai, Takeshi Kodaira, Sadamoto Zenda, Hirofumi Fujii, Makoto Tahara, Tomoya Yokota, Tetsuo Akimoto, Shigemichi Iwae, Tetsuro Onitsuka, Takenori Ogawa, Susumu Okano, Shunji Takahashi, Yasushi Shimizu, (unknown), Ryuichi Hayashi	25
17	Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma 2018 ·Cancer Research ·Teruki Yanagi, Masashi Watanabe, Hiroo Hata, Shinya Kitamura, Keisuke Imafuku, (unknown), Akihiro Homma, (unknown), Hidehisa Takahashi, Hiroshi Shimizu, Shigetsugu Hatakeyama	40
18	Usefulness of Pseudocontinuous Arterial Spin-Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period 2015 ·American Journal of Neuroradiology ·Noriyuki Fujima, Daisuke Yoshida, Tomohiro Sakashita, Akihiro Homma, Akiko Tsukahara, Khin Khin Tha, Kohsuke Kudo, Hiroki Shirato	28
19	Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: Assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI 2014 ·Magnetic Resonance Imaging ·Noriyuki Fujima, Daisuke Yoshida, Tomohiro Sakashita, Akihiro Homma, Akiko Tsukahara, Khin Khin Tha, Kohsuke Kudo, Hiroki Shirato	67
20	The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation 2013 ·European Archives of Oto-Rhino-Laryngology ·Tomohiro Sakashita, Akihiro Homma, Hiromitsu Hatakeyama, Satoshi Kano, Takatsugu Mizumachi, (unknown), Daisuke Yoshida, Noriyuki Fujima, Rikiya Onimaru, Kazuhiko Tsuchiya, Kôichi Yasuda, Hiroki Shirato, Satoshi Fukuda	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact